Alyeska Investment Group
APGN

Alyeska Investment Group’s Apexigen, Inc. Common Stock APGN Stock Holding History

Alyeska Investment Group’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,000
Closed -$171K – 687
2022
Q1 		$171K Hold
17,000
– – ﹤0.01% 570
2021
Q4 		$170K Hold
17,000
– – ﹤0.01% 587
2021
Q3 		$169K Hold
17,000
– – ﹤0.01% 662
2021
Q2 		$169K Hold
17,000
– – ﹤0.01% 689
2021
Q1 		$167K Buy
+17,000
New +$170K ﹤0.01% 707

Other funds holding APGN

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Alyeska Investment Group's APGN Position: Q2 2022 in Review

Alyeska Investment Group sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 17,000 shares — an estimated $171K sold.

Alyeska Investment Group first reported a position in APGN in Q1 2021 and held it in 5 quarters. The position peaked at $171K in Q1 2022. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

  • Alyeska Investment Group reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 17,000 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $171K.
  • Alyeska Investment Group first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Alyeska Investment Group's Apexigen, Inc. Common Stock position peaked at $171K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Alyeska Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.